<DOC>
	<DOCNO>NCT03104036</DOCNO>
	<brief_summary>The etiopathogenesis ulcerative colitis ( UC ) fully understood . One theory UC pathogenesis represent pathological response mucosal immunity intestinal microbiota . Potential therapeutic procedure affect fact faecal microbiota transplantation ( FMT ) . Review literature FMT suggest great potential treatment UC , two prospective control study publish yet inconsistent . The first objective project compare administration FMT enema mesalazine enema induce remission patient active left-sided UC form prospective , randomize , control study . The second objective observe change intestinal microbiota FMT focus bacterial DNA sequence identify bacterial specie responsible effect FMT .</brief_summary>
	<brief_title>Faecal Bacteriotherapy Ulcerative Colitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Mesalamine</mesh_term>
	<criteria>Leftsided ulcerative colitis &gt; 15cm ongoing 3 month Mayo score &lt; 10 Endoscopic Mayo score â‰¥ 2 AntiTNF medication previous 6 month Cyclosporine previous 4 week Methotrexate previous 2 month Prednisone &gt; 10mg The real risk colectomy near future Positive stool culture ( Salmonella , Shigella , Yersinia , Campylobacter , pathogenic E. coli ) CMV infection Pregnancy , breastfeed woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Feacal bacterial transplantation</keyword>
	<keyword>Left-sided ulcerative colitis</keyword>
</DOC>